Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today
WEB4 days ago · The company is forging ahead with next-generation drug development solutions. Bioengineering specialist Ginkgo Bioworks Holdings (DNA 0.37%) delivered some badly needed good news for investors on ...
Ginkgo Bioworks Announces Acquisition of AgBiome’s Platform …
WEBApr 11, 2024 · We’re thrilled to announce the acquisition of AgBiome’s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as …
Google Cloud Expands Its Partnership With Ginkgo Bioworks For …
WEB5 days ago · Tuesday, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) announced two tools to streamline the drug development process for pharmaceutical and biotech companies. Building on its partnership with ...
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI …
WEB4 days ago · Share this article. BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the ...
Syngenta collaborates with Ginkgo Bioworks
WEBJul 16, 2024 · Today, we announced a new collaboration with Syngenta Crop Protection, a leader in agricultural innovation, aimed at accelerating the launch of a new biological solution. We’ve previously collaborated on next-generation seed technology.
AminoAcid-0 (AA-0): A Protein LLM Trained with 2 Billion …
WEB5 days ago · We compare the performance of AA-0 to ESM-2 on popular benchmarks as well as a collection of internal benchmarks relevant to our commercial work in the Ginkgo Bioworks foundry. AA-0 performs comparably to ESM-2 across a range of 235 external and 73 internal protein engineering tasks. Although …
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform …
WEBApr 11, 2024 · Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000...
Ginkgo Bioworks Completes Program with Biogen to Boost …
WEBJan 4, 2024 · Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the successful completion of the gene therapy collaboration they...
Ginkgo Bioworks Holdings: A Buy Rating on Strategic AI …
WEB2 days ago · Brendan Smith, an analyst from TD Cowen, maintained the Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report). The associated price target is $10.00. The associated price target is $10.00.
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI
WEB4 days ago · BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo Datapoints to usher in the next era of biotechnology by making the training of AI models easier and more efficient. Ginkgo Datapoints is specialized in generating large, high-quality biological datasets ...